Genetic architecture of plasma pTau217 and related biomarkers in Alzheimer's disease via genome-wide association studies.

Key Points

The study aims to explore the genetic factors influencing plasma pTau217 and related biomarkers in Alzheimer's disease.
Conducted genome-wide association studies
Analyzed genetic data linked to Alzheimer's disease biomarkers
Investigated ancestry-related genetic impacts
Found significant links between genetics of biomarkers and brain regulatory mechanisms
Supported integrative causal analyses related to Alzheimer's disease

Answers are grounded in this paper and cite their sources.

Genome-wide association studies link AD biomarker genetics to brain mechanisms, suggesting new insights.

These findings link ancestry-relevant AD biomarker genetics to brain regulatory mechanisms and support integrative causal analyses.

No takes yet. Share an insight, caveat, or question.

Kim et al. (2026) studied this question.

View at Publisher

Ask AI

Bookmark

Share